Historique de carrière de Annette Eschler
Anciens postes connus de Annette Eschler
Sociétés | Poste | Début | Fin |
---|---|---|---|
ACINO HOLDING AG | Corporate Officer/Principal | 17/05/2010 | 01/04/2011 |
Cimex AG | Corporate Officer/Principal | 01/01/2008 | 01/01/2008 |
Ratiopharm GmbH
Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Corporate Officer/Principal | 01/01/2006 | 01/01/2006 |
Formation de Annette Eschler
Universität Ulm | Doctorate Degree |
Statistiques
Internationale
Suisse | 3 |
Allemagne | 3 |
Opérationnelle
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Ratiopharm GmbH
Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Health Technology |
Cimex AG |
- Bourse
- Insiders
- Annette Eschler
- Expérience